|
2023
|
Invention
|
1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinas... |
|
2020
|
Invention
|
Inhibitor of p38 map kinase. A compound has the following formula:
The compound is a p38 MAP ki... |
|
|
Invention
|
Indole derivatives and their use as protein kinase inhibitors. The present invention relates inte... |
|
2019
|
Invention
|
Pyrazolyl-ureas as kinase inhibitors. There are provided compounds of formula (I) as defined in t... |
|
|
Invention
|
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 map knase inhibit... |
|
|
Invention
|
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as p38 mapkinase inhibit... |
|
2018
|
Invention
|
Inhibitor of p38 map kinase. A dry powder pharmaceutical formulation for inhalation including a c... |
|
|
Invention
|
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 map kinase inhibi... |
|
2017
|
Invention
|
Pyrazolyl ureas as kinase inhibitors. There are provided compounds of formula (I) shown below as ... |
|
|
Invention
|
Compounds.
The present invention relates to compounds of formula (I)
The present invention rel... |
|
|
Invention
|
Inhibitors of hemopoietic cell kinase (p-59-hck) and their use in the treatment of influenza infe... |
|
|
Invention
|
Pyrazole p38 map kinase inhibitors. There are provided inter alia compounds of formula (I)
6 are... |
|
|
Invention
|
2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluor... |
|
|
Invention
|
Crystalline pl3 kinase inhibitors.
There is provided inter alia 6-(2-((4-amino-3-(3-hydroxypheny... |
|
|
Invention
|
Quinazolin-4 (3h)-one derivatives used as p13 kinase inhibitors. The present invention relates to... |
|
|
Invention
|
Indole derivatives and their use as protein kinase inhibitors. 3, are as defined in the specifica... |
|
2016
|
Invention
|
Indolinones compounds and their use in the treatment of fibrotic diseases. 3 and Z are as defined... |
|
|
Invention
|
Indolinones compounds and their use in the treatment of fibrotic diseases. The present invention ... |
|
|
Invention
|
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 map knase inhibitor... |
|
|
Invention
|
Inhibitor of p38 map kinase. A compound of formula (XV):
1 represents an amino group, a prot... |
|
|
Invention
|
Compounds. The present invention relates to compounds of formula (I)
and to compositions compri... |
|
|
Invention
|
P38 map kinase inhibitors. There is provided inter alia a compound of formula (I):
4 are as defi... |
|
2015
|
Invention
|
Phosphoinositide 3-kinase inhibitors. The present invention relates inter alia to a compound of f... |
|
|
Invention
|
Ureido-pyrazole derivatives.
The disclosure relates to compounds of formula (I) for use in the t... |
|
|
Invention
|
Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infec... |
|
|
Invention
|
Kinase inhibitors.
Compounds of formula I,
Compounds of formula I,
Compounds of formula ... |
|
|
Invention
|
N-phenyl-3-quinazolin-6-yl-benzamide derivatives as p38 kinase inhibitors. There are provided com... |
|
|
Invention
|
Diaryl urea derivatives as p38 kinase inhibitors. There are provided compounds of formula I, wher... |
|
|
Invention
|
4-(4-(4-phenylureido-naphthalen-1-yl)oxy-pyridin-2-yl)amino-benzoic acid derivative as p38 kinase... |
|
|
Invention
|
Substituted 1-pyrazolyl-3-naphthyl-urea compound with anti-inflammatory properties. There is prov... |
|
|
Invention
|
Aromatic heterocyclic compounds as antiinflammatory compounds. There is provided a compound of fo... |
|
2014
|
Invention
|
Respiratory formulations and compounds for use therein. The present invention relates to respirat... |
|
|
Invention
|
2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-(trifluoro... |
|
|
Invention
|
Kinase inhibitors.
There are provided compounds of formula I,
There are provided compounds of ... |
|
2013
|
Invention
|
Kinase inhibitors.
There are provided compounds of formula (I),
There are provided compounds o... |
|
2012
|
Invention
|
1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 map kinase inhib... |
